Genetic Variation Impacts Pharmacokinetics of Exemestane
Significant differences in plasma exemestane area under the curve for OATP1B1 genotype groups
Centralized Mailings Can Improve CRC Screening Adherence
Participants randomized to receive mailings had 31 percent more adjusted covered time over five years
FDA Approves New Treatment for Acute Myeloid Leukemia
Vyxeos combines two previously approved drugs -- daunorubicin and cytarabine
FDA Approves Idhifa for Some With Acute Myeloid Leukemia
For adults with relapsed or refractory AML who have an IDH2 genetic mutation
FDA Approves Imbruvica to Treat Chronic Graft Versus Host Disease
Drug sanctioned for patients with cGVHD who do not respond to other forms of therapy
Revenue Exceeds Expenditures for Many ABMS Member Boards
Change in net balance of American Board of Medical Specialties member boards grew from 2003 to 2013
Mechanisms ID’d for Curcumin Resensitization of Cancer Cells
Compound helps turn off pathways linked to chemoresistance in pancreatic ductal adenocarcinoma
July 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for July 2017. This roundup includes...
Climate Change Expected to Up Premature Deaths From Pollution
Premature mortality attributable to climate change estimated to be greatest in India, East Asia
Periodontal Disease History Linked to Increased Cancer Risk
For older women, risk of total cancer, melanoma, and breast, lung, esophagus, gallbladder cancers up
